| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.3816/CBC.2001.N.022 |
| P698 | PubMed publication ID | 11899413 |
| P2093 | author name string | Martín M | |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | platinum | Q880 |
| P304 | page(s) | 190-208; discussion 209 | |
| P577 | publication date | 2001-10-01 | |
| P1433 | published in | Clinical Breast Cancer | Q332245 |
| P1476 | title | Platinum compounds in the treatment of advanced breast cancer | |
| P478 | volume | 2 |
| Q58803112 | A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer |
| Q27305830 | Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicity |
| Q37355031 | BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells |
| Q45150963 | Bilateral inflammatory metachronic ERBB2 (HER2/neu)-positive breast carcinoma: prolonged survival with combined chemotherapy and trastuzumab |
| Q59565062 | Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial |
| Q29617899 | Cellular processing of platinum anticancer drugs |
| Q30513775 | Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy |
| Q36322416 | Contrasting effect of recombinant human erythropoietin on breast cancer cell response to cisplatin induced cytotoxicity |
| Q35064126 | Emerging cancer-targeted therapies |
| Q57142532 | Emerging drugs in metastatic breast cancer |
| Q34636502 | Expression microarray analysis reveals genes associated with in vitro resistance to cisplatin in a cell line model |
| Q34713757 | Higher rate of skin rash in a phase II trial with weekly nanoparticle albumin-bound paclitaxel and cisplatin combination in Chinese breast cancer patients |
| Q38161367 | Immune modulation by chemotherapy or immunotherapy to enhance cancer vaccines |
| Q50193922 | Inhibited, trapped or adducted: the optimal selective synthetic lethal mix for BRCAness |
| Q89880373 | Maintenance chemotherapy after 6 cycles of platinum-doublet regimen in anthracycline-and taxane-pretreated metastatic breast cancer |
| Q37230098 | Phase II study of gemcitabine plus cisplatin in patients with anthracycline- and taxane- pretreated metastatic breast cancer |
| Q35650449 | Platinum-based chemotherapy in metastatic breast cancer: current status. |
| Q37570886 | Polysaccharide from Sepia esculenta ink and cisplatin inhibit synergistically proliferation and metastasis of triple-negative breast cancer MDA-MB-231 cells |
| Q35749321 | Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells |
| Q37333198 | The Renaissance of platinum-based chemotherapy for metastatic breast cancer |
Search more.